Amisulpride Tablets
This product is indicated for the treatment of acute or chronic schizophrenia dominated by positive symptoms (delirium, hallucination, cognitive impairment, etc.) and/or negative symptoms (psychomotor retardation, apathy, social withdrawal, etc.). It is also effective for schizophrenia characterized by negative symptoms.
Product Category：
Product Description
[Product Name] Baiyoulin®
[Generic Name] Amisulpride Tablets
[Approval No.] 100 mg: GYZZ H20203564; 200 mg: GYZZ H20203565
[Specification] YBH11362020
[Dosage and Administration] If the daily dose is ≤400 mg, it should be taken all at once; if the daily dose is >400 mg, it should be taken in two divided doses.
[Age of Use] Over 18 years old, see package insert for details
[Strength] 100 mg*30 tablets/carton; 200 mg*20 tablets/carton
[Storage] Store in airtight containers at room temperature
[Shelf Life] 24 months
[Manufacturer] Xiamen Lizhuo Pharmaceutical Co., Ltd.
[Drug Marketing Authorization Holder] Shenzhen Foncoo Pharmaceutical Co., Ltd.
ONLINE MESSAGE
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible
Related Products
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No. 1001, Xueyuan Avenue, Changyuan Community, Taoyuan Street, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED